Fermentas
 | This article needs more citations. (July 2020) |
 | |
| Type | Public (NYSE: TMO) |
|---|---|
| Founded | 3 March 1994  |
| Headquarters | Waltham, Massachusetts, USA |
| Key people | Marc N. Casper (President & CEO) |
| Revenue | 1,476,888,454 (2022) |
| 554,487,842 (2022) | |
| Total assets | 736,264,315 (2022) |
Number of employees | 1,520 (2022) |
| Parent | Thermo Fisher Scientific |
| Website | www.thermofisher.com |
Fermentas was a biotechnology company specializing in the discovery and production of molecular biology products for life science research and diagnostics. In 2010, Fermentas was acquired by Thermo Fisher Scientific for $260M.[1]
Corporate profile
[edit]In 2003, Fermentas consolidated its international business and set up a controlling enterprise, Fermentas International, in Canada. Fermentas International became the shareholder of Fermentas in Vilnius, Lithuania, and its joint ventures in the United States, Canada and Germany[2] (as well as Fermentas China established in 2009).[citation needed]
In 2010, Fermentas International was acquired by Thermo Fisher Scientific for $260M.[3] Fermentas, and all of its enterprises, became part of the Analytical Technology segment of the Thermo Fisher.[1]
Fermentas has principal manufacturing operations in Vilnius, Lithuania. More than 99% of production was destined for export markets.[4]
Products
[edit]Fermentas is a producer of molecular biology products and is known for its restriction enzymes and DNA ladders and molecular weight markers.[5]
The company's main products are FastDigest and conventional restriction enzymes, DNA/RNA modifying enzymes, transfection reagents, nucleotides and primers, products of PCR and RT-PCR, molecular cloning, nucleic acid purification, in vitro transcription, molecular labeling and detection, DNA, RNA, protein electrophoresis.[6]
All Fermentas’ products are produced in Class D clean-room facilities, qualified and certified as per EU directives and International Society for Pharmaceutical Engineering (ISPE) guidelines, which are prerequisite for GMP manufacturing. The company is operating under ISO9001, ISO13485 quality and ISO14001 environmental management systems.[7][8]
References
[edit]- 1 2 "Thermo Fisher Scientific to Purchase Fermentas for $260M". Genetic Engineering and Biotechnology News. 27 May 2010.
- ↑ "Fermentas International Inc. - [LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal". www.life-sciences-europe.com. Retrieved 2026-10-04.
- ↑ "Thermo Fisher Scientific's success story in Lithuania". Invest Lithuania. Retrieved 2026-10-04.
- ↑ ""Fermentas" gamybą modernizuoja savo lėšomis". DELFI (in Lithuanian). 2006-12-04. Archived from the original on 2023-02-02. Retrieved 2023-02-02.
- ↑ ""Fermentas" pasirengęs šuoliui". Kauno diena (in Lithuanian). 2008-01-15. Archived from the original on 2023-02-02. Retrieved 2023-02-02.
- ↑ "Fermentas Learned Fast How to Go Global". GEN - Genetic Engineering and Biotechnology News. 2008-03-15. Retrieved 2026-10-04.
- ↑ "Gamybinė technologinė praktika UAB Thermo Fisher Scientific Baltics". Moksliniaidarbai.lt. 2017-07-16. Archived from the original on 2023-02-02. Retrieved 2023-02-02.
- ↑ "PDF" (PDF). tuvuolektis.lt. 2011-09-09. Archived from the original (PDF) on 2023-02-02. Retrieved 2023-02-02.